A study to evaluate the efficacy and safety of bintrafusp alfa (M7824) monotherapy in metastatic or locally advanced urothelial cancer

Trial Identifier: 213152
Sponsor: GlaxoSmithKline
Collaborator:
Merck KGaA
Start Date: October 2020
Primary Completion Date: August 2022
Study Completion Date: August 2022
Condition: Cancer - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
Canada, Ontario Toronto, Ontario, Canada, M5G 2M9
France Bordeaux, France, 33000
France Poitiers Cedex, France, 86021
France Toulouse Cedex 9, France, 31059
France Villejuif Cedex, France, 94805
Netherlands Amsterdam, Netherlands, 1066 CX
Spain Barcelona, Spain, 08035
Spain Madrid, Spain, 28040
Spain Sevilla, Spain, 41013
Spain, Madrid Madrid, Spain, 28041
United States, New York Lake Success, New York, United States, 11041
United States, Ohio Cincinnati, Ohio, United States, 45229